SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Alps Group Inc
Date: Sept. 11, 2025 · CIK: 0002025774 · Accession: 0001493152-25-013057

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284035

Date
Sept. 11, 2025
Author
ALPS
Form
CORRESP
Company
Alps Group Inc

Letter

VIA EDGAR

September 11, 2025

Division of Corporation Finance

Office of Industrial Applications and Services

U.S. Securities & Exchange Commission

F Street, NE

Washington, D.C. 20549

Attention: Conlon Danberg

Lauren Nguyen Nudrat Salik

Li Xiao

Re: Alps Global Holding Pubco

Registration Statement on Form F-4

File No. 333-284035

Ladies and Gentlemen:

Pursuant to Rule 461 of Regulation C ("Rule 461") promulgated under the Securities Act of 1933, as amended, Alps Global Holding Pubco (the "Registrant") and Alps Life Sciences Inc. (the "Co-Registrant") hereby request that the effectiveness of the above-referenced registration statement on Form F-4, as amended (the "F-4 Registration Statement"), be accelerated to, and that the F-4 Registration Statement become effective at, 5:00 p.m., Eastern Time on September 12, 2025, or as soon thereafter as practicable. If there is any change in the acceleration request set forth above, the Registrant and Co-Registrant will promptly notify you of the change, in which case the Registrant and Co-Registrant may be making an oral request of acceleration of the effectiveness of the F-4 Registration Statement in accordance with Rule 461. Such request may be made by an executive officer of the Registrant and Co-Registrant or by any attorney from their U.S. counsel, Law Offices of Jenny Chen-Drake.

Very truly yours,

ALPS GLOBAL HOLDING PUBCO

/s/ Tham Seng Kong

Tham Seng Kong

Chief Executive Officer of Alps Global Holding Pubco

Very
truly yours,
ALPS
LIFE SCIENCES INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 VIA
EDGAR

 September
11, 2025

 Division
of Corporation Finance

 Office
of Industrial Applications and Services

 U.S.
Securities & Exchange Commission

 100
F Street, NE

 Washington,
D.C. 20549

 Attention:
 Conlon
 Danberg

 Lauren
 Nguyen
 Nudrat
 Salik

 Li
 Xiao

 Re:
 Alps
 Global Holding Pubco

 Registration
 Statement on Form F-4

 File
 No. 333-284035

 Ladies
and Gentlemen:

 Pursuant
to Rule 461 of Regulation C ("Rule 461") promulgated under the Securities Act of 1933, as amended, Alps Global Holding Pubco
(the "Registrant") and Alps Life Sciences Inc. (the "Co-Registrant") hereby request that the effectiveness of
the above-referenced registration statement on Form F-4, as amended (the "F-4 Registration Statement"), be accelerated to,
and that the F-4 Registration Statement become effective at, 5:00 p.m., Eastern Time on September 12, 2025, or as soon thereafter
as practicable. If there is any change in the acceleration request set forth above, the Registrant and Co-Registrant will promptly notify
you of the change, in which case the Registrant and Co-Registrant may be making an oral request of acceleration of the effectiveness
of the F-4 Registration Statement in accordance with Rule 461. Such request may be made by an executive officer of the Registrant and
Co-Registrant or by any attorney from their U.S. counsel, Law Offices of Jenny Chen-Drake.

 Very
 truly yours,

 ALPS
 GLOBAL HOLDING PUBCO

 /s/
 Tham Seng Kong

 Tham
 Seng Kong

 Chief
 Executive Officer of Alps Global Holding Pubco

 Very
 truly yours,

 ALPS
 LIFE SCIENCES INC.

 /s/
 Tham Seng Kong

 Tham
 Seng Kong

 Group
 Chief Executive Officer of Alps Life Sciences Inc.